Literature DB >> 19843423

Commentary: What's so special about familial hypercholesterolaemia?

David Mant1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19843423      PMCID： PMC2751921          DOI： 10.3399/bjgp09X472683

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  9 in total

1.  Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing.

Authors:  Brian Starr; S Gaye Hadfield; Barbara A Hutten; Peter J Lansberg; Trond P Leren; Dorte Damgaard; H Andrew W Neil; Steve E Humphries
Journal:  Clin Chem Lab Med       Date:  2008       Impact factor: 3.694

2.  Identifying patients with familial hypercholesterolaemia in primary care.

Authors:  Steve E Humphries; Gaye Hadfield
Journal:  Heart       Date:  2008-06       Impact factor: 5.994

3.  Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia.

Authors:  N J Stone; R I Levy; D S Fredrickson; J Verter
Journal:  Circulation       Date:  1974-03       Impact factor: 29.690

4.  Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia.

Authors:  Dalya Marks; David Wonderling; Margaret Thorogood; Helen Lambert; Steve E Humphries; H Andrew W Neil
Journal:  BMJ       Date:  2002-06-01

5.  Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia.

Authors:  D Bhatnagar; J Morgan; S Siddiq; M I Mackness; J P Miller; P N Durrington
Journal:  BMJ       Date:  2000-12-16

6.  Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands.

Authors:  M A Umans-Eckenhausen; J C Defesche; E J Sijbrands; R L Scheerder; J J Kastelein
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

7.  Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes.

Authors:  D Marks; M Thorogood; S M Neil; S E Humphries; H A W Neil
Journal:  J Med Screen       Date:  2006       Impact factor: 2.136

Review 8.  Identification and management of familial hypercholesterolaemia: what does it mean to primary care?

Authors:  Nadeem Qureshi; Steve E Humphries; Mary Seed; Philip Rowlands; Rubin Minhas
Journal:  Br J Gen Pract       Date:  2009-10       Impact factor: 5.386

9.  Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.

Authors: 
Journal:  Atherosclerosis       Date:  1999-01       Impact factor: 5.162
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.